Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Jim Cramer - Mad MoneyInsmed INSMWATCHJan 05, 2026

Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.

$175.20

Stock price when the opinion was issued

$97.85

As of Jun 12, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

Too speculative. They lose money.